Adrenomedullin signaling is necessary for murine lymphatic vascular development
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The lymphatic vascular system mediates fluid homeostasis, immune defense, and tumor metastasis. Only a handful of genes are known to affect the development of the lymphatic vasculature, and even fewer represent therapeutic targets for lymphatic diseases. Adrenomedullin (AM) is a multifunctional peptide vasodilator that transduces its effects through the calcitonin receptor-like receptor (calcrl) when the receptor is associated with a receptor activity-modifying protein (RAMP2). Here we report on the involvement of these genes in lymphangiogenesis. AM-, calcrl-, or RAMP2-null mice died mid-gestation after development of interstitial lymphedema. This conserved phenotype provided in vivo evidence that these components were required for AM signaling during embryogenesis. A conditional knockout line with loss of calcrl in endothelial cells confirmed an essential role for AM signaling in vascular development. Loss of AM signaling resulted in abnormal jugular lymphatic vessels due to reduction in lymphatic endothelial cell proliferation. Furthermore, AM caused enhanced activation of ERK signaling in human lymphatic versus blood endothelial cells, likely due to induction of CALCRL gene expression by the lymphatic transcriptional regulator Prox1. Collectively, our studies identify a class of genes involved in lymphangiogenesis that represent a pharmacologically tractable system for the treatment of lymphedema or inhibition of tumor metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic deficiency in either adrenomedullin, Calcrl, or Ramp2 (27,57,74) is embryonic lethal at midgestation because of cardiovascular defects and a hypoproliferative lymphatic vasculature, whereas Ramp1 KO and Ramp3 KO are viable (57,131,203).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Calcrl Calcitonin receptor-like receptor (CRLR) Embryonic lethal (57, 74)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Ramp2 RAMP2 Embryonic lethal (74)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“The ligand-binding affinity of CLR (and other class II GPCRs) can be changed via receptor interaction with a class of single-pass transmembrane proteins called receptor activity–modifying proteins (RAMPs) (29).”
BackgroundInduction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Prox1 Function Is Required for the Development of the Murine Lymphatic System
Wigle, J. T., & Oliver, G. (1999) · Cell · doi:10.1016/s0092-8674(00)81511-1 · Cited by 1,579 · cited 5×
“Therefore, we transfected a hProx1 expression plasmid into cultured HMVEC-dLys and measured mRNA production of endogenous LYVE and CALCRL.”
BackgroundResultInfluentialKarkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421 · cited 3×
“Thus, based on the absence of blood hemorrhage, the presence of embryonic lymphedema, and the fact that the edematous phenotype of AM signaling–null mice more closely resembled that of other mouse models with defects in lymphangiogenesis (10, 11, 14) rather than defects in blood vascular permeability (40–43), we hypot…”
BackgroundLymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285 · cited 2×
“While a few of these gene products, such as VEGFC and angiopoietins, show promise as potential targets for the stimulation, inhibition, or modulation of lymphangiogenesis and lymphatic function in lymphedematous tissues or tumors of adult animals (17), there remains a crucial need to identify additional genetic and ph…”
BackgroundOptical Projection Tomography as a Tool for 3D Microscopy and Gene Expression Studies
Sharpe, J., Ahlgren, U., Perry, P., Hill, B., Ross, A., Hecksher-Sørensen, J., Baldock, R., & Davidson, D. (2002) · Science · doi:10.1126/science.1068206 · Cited by 1,158
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1505 · Cited by 943 · cited 2×
“Prox1 is expressed in a polarized fashion in the venous endothelium and serves as a master switch for establishing LEC competence (9).”
BackgroundT1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
Schacht, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg342 · Cited by 653 · cited 1×
“Finally, several genes have been implicated in the later stages of lymphatic vessel patterning and postnatal maturation, including podoplanin (13), neuropillin2 (14), FoxC2 (15), and angiopoietin-2 (16).”
BackgroundPetrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf470 · Cited by 632 · cited 1×
“Several comparative transcriptional profiling studies have shown enhanced expression of AM signaling genes in lymphatic versus blood endothelial cells (46, 47) and lymphedematous versus normal vasculature (48).”
BackgroundAbnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Research works printed but not linked: 3
- Kato, 1997, Endocrinology., 138, 2615, 10.1210/endo.138.6.5197 · doi:10.1210/endo.138.6.5197 · Paper page
- Doods, 2001, Curr. Opin. Investig. Drugs., 2, 1261
- Del Pup, 2003, Int J Mol Med, 11, 157
Cited by
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
“Mice deficient in the vasodilator and diuretic peptide adrenomedullin (AM) or components of its receptor complex (calcitonin receptor-like receptor and receptor activity-modifying protein 2 [RAMP2]) develop edema and embryonic lethality at midgestation (Fritz-Six et al., 2008).”
BackgroundLymphatic vascular morphogenesis in development, physiology, and disease
Schulte-Merker, S., Sabine, A., & Petrova, T. V. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201012094 · Cited by 394
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
Gaengel, K., Niaudet, C., Hagikura, K., Laviña, B., Muhl, L., Hofmann, J. J., Ebarasi, L., Nyström, S., Rymo, S., Chen, L. L., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.005 · Cited by 317
“5 as a result of vascular abnormalities (Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
BackgroundThe Lymphatic System in Health and Disease
Cueni, L. N., & Detmar, M. (2008) · Lymphatic Research and Biology · doi:10.1089/lrb.2008.1008 · Cited by 288
“89 The Lymphatic System in Disease”
Development of the mammalian lymphatic vasculature
Yang, Y., & Oliver, G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71609 · Cited by 226
“the components of adrenomedullin signaling (adrenomedullin and its receptors Calcr1 and Ramp2) results in hypoplastic lymph sacs and subcutaneous edema (48).”
Christiansen, A., & Detmar, M. (2011) · Genes & Cancer · doi:10.1177/1947601911423028 · Cited by 200
Nociceptive nerves regulate haematopoietic stem cell mobilization
Gao, X., Zhang, D., Xu, C., Li, H., Caron, K. M., & Frenette, P. S. (2021) · Nature · doi:10.1038/s41586-020-03057-y · Cited by 186
Self-citationA compact VEGF signature associated with distant metastases and poor outcomes
Hu, Z., Fan, C., Livasy, C., He, X., Oh, D. S., Ewend, M. G., Carey, L. A., Subramanian, S., West, R., Ikpatt, F., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-9 · Cited by 183
“As a step in evaluating this profile, we performed ISH to determine what cell type was producing VEGF, ANGPTL4 and ADM.”
InfluentialLymphatic regulator PROX1 determines Schlemm’s canal integrity and identity
Park, D.-Y., Lee, J., Park, I., Choi, D., Lee, S., Song, S., Hwang, Y., Hong, K. Y., Nakaoka, Y., Makinen, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75392 · Cited by 174
Lymphangiogenesis guidance by paracrine and pericellular factors
Vaahtomeri, K., Karaman, S., Mäkinen, T., & Alitalo, K. (2017) · Genes & Development · doi:10.1101/gad.303776.117 · Cited by 176
“Thus, dynamic modulation of CXCL12, adrenomedullin, and CXCR7 levels in the two vascular systems could potentially regulate their alignment and separation fromeachother at later developmental stages (Boldajipour et al. 2008).”
BackgroundInfluentialBiological Basis of Therapeutic Lymphangiogenesis
Norrmén, C., Tammela, T., Petrova, T. V., & Alitalo, K. (2011) · Circulation · doi:10.1161/circulationaha.107.704098 · Cited by 171
Lymphangiogenesis and cancer metastasis
Mumprecht, V., & Detmar, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00834.x · Cited by 171
Mechanoinduction of lymph vessel expansion
Planas‐Paz, L., Strilić, B., Goedecke, A., Breier, G., Fässler, R., & Lammert, E. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.456 · Cited by 171
“5 of embryonic development (Karkkainen et al , 2004; Fritz-Six et al , 2008; D’Amico et al , 2010), showing dysfunctional fluid drainage at E12.”
Tumor lymphangiogenesis and melanoma metastasis
Rinderknecht, M., & Detmar, M. J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21494 · Cited by 169
“Very recently, it was shown that the known vasodilator adrenomedullin, acting via calcitonin receptor-like receptor (calcrl) and receptor activity-modifying protein-2 (RAMP2), also promotes lymphangiogenesis (Fritz-Six et al., 2008).”
BackgroundDieterich, L. C., Tacconi, C., Ducoli, L., & Detmar, M. J. (2022) · Physiological Reviews · doi:10.1152/physrev.00039.2021 · Cited by 179
The Intestinal Lymphatic System: Functions and Metabolic Implications
Cifarelli, V., & Eichmann, A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.12.002 · Cited by 168
Shin, J. W., Huggenberger, R., & Detmar, M. (2008) · Blood · doi:10.1182/blood-2008-05-156331 · Cited by 148
Lin, F.-J., Chen, X., Qin, J., Hong, Y.-K., Tsai, M.-J., & Tsai, S. Y. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40101 · Cited by 143
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“(119) Calcrl Calcitonin receptor–like receptor (CRLR) Embryonic lethal (57, 74) Ramp1 Receptor activity–modifying protein (RAMP)1 NA Ramp2 RAMP2 Embryonic lethal (74) Ramp2 / (hemizygous): delayed bone development, reduced mineral content, and mineral density.”
BackgroundInfluentialCyclooxygenase-2–dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer
Lyons, T. R., Borges, V. F., Betts, C. B., Guo, Q., Kapoor, P., Martinson, H. A., Jindal, S., & Schedin, P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73777 · Cited by 134
“Furthermore, multiple prolymphangiogenic molecules have been proposed as candidates for safe pharmacological inhibition of lymphangiogenesis (47–50), and monoclonal antibody–based antilymphatic therapies are already in clinical trials (30, 51).”
Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature
Koltowska, K., Betterman, K. L., Harvey, N. L., & Hogan, B. M. (2013) · Development · doi:10.1242/dev.089565 · Cited by 143
“Mice carrying targeted mutations of Adm (adrenomedullin), Ramp2 or Calcrl (receptors for adrenomedullin) exhibit hypoplastic jugular lymph sacs and pronounced subcutaneous oedema (Fritz-Six et al., 2008).”
BackgroundRan, S., & Montgomery, K. E. (2012) · Cancers · doi:10.3390/cancers4030618 · Cited by 131
“Several other products of activated macrophages such as PDGF [110], adrenomedullin [164], and HGF/SF [166] act directly on LEC that express corresponding receptors.”
BackgroundRockson, S. G. (2021) · Circulation Research · doi:10.1161/circresaha.121.318307 · Cited by 152
Lymphatic endothelium in health and disease
Jurisic, G., & Detmar, M. J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0644-2 · Cited by 132
“Adrenomedullin, known as a potent vasodilator, has been recently found to play a role in lymphatic development based on studies in several knockout mouse models (Fritz-Six et al. 2008).”
BackgroundGastrointestinal lymphatics in health and disease
Alexander, J. S., Ganta, V. C., Jordan, P., & Witte, M. H. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.09.003 · Cited by 119
“AM is necessary for vascular development [40], induces lymphangiogenesis, and plays a major role in attenuating lymphedema [41].”
Pedrioli, D. M. L., Kärpänen, T., Dabouras, V., Jurisic, G., van de Hoek, G., Shin, J. W., Marino, D., Kälin, R. E., Leidel, S. A., Cinelli, P., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00185-10 · Cited by 109
Decoy Receptor CXCR7 Modulates Adrenomedullin-Mediated Cardiac and Lymphatic Vascular Development
Klein, K. R., Karpinich, N. O., Espenschied, S. T., Willcockson, H. H., Dunworth, W. P., Hoopes, S. L., Kushner, E. J., Bautch, V. L., & Caron, K. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.07.012 · Cited by 116
“…CXCR7 was originally identified as RDC1—a putative receptor for adrenomedullin (Adm, gene; AM, protein), a 52 amino acid mitogenic peptide hormone critical for cardiac and lymphatic vascular development (Caron and Smithies, 2001; Dackor et al., 2006; Dunworth et al., 2008; Fritz-Six et al., 2008).”
BackgroundSelf-citationDunworth, W. P., Cardona-Costa, J., Çağavi, E., Kim, J., Meadows, S. M., Fischer, J. C., Wang, Y., Cleaver, O. B., Qyang, Y., Ober, E. A., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.302452 · Cited by 103
Self-citationLymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets
Hu, Z., Zhao, X., Wu, Z., Qu, B., Yuan, M., Xing, Y., Song, Y., & Wang, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01723-x · Cited by 129
“56 63 In addition to biochemical pathways, mechanical force can activate lymphangiogenesis in this stage.”
BackgroundWallgard, E., Larsson, E., He, L., Hellström, M., Armulik, A., Nisancioglu, M. H., Genové, G., Lindahl, P., & Betsholtz, C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165738 · Cited by 110
Developmental and pathological lymphangiogenesis: from models to human disease
Hajjami, H. M.-E., & Petrova, T. V. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0525-5 · Cited by 122
“Adrenomedullin (AM), a vasodilatator and diuretic peptide, is necessary for murine lymphatic vascular development (Fritz-Six et al. 2008; Jin et al. 2008).”
BackgroundWeston, C., Winfield, I., Harris, M., Hodgson, R., Shah, A., Dowell, S. J., Mobarec, J. C., Woodlock, D. A., Reynolds, C. A., Poyner, D. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751362 · Cited by 95
Lymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases
Zhang, F., Zarkada, G., Yi, S., & Eichmann, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00509 · Cited by 108
Development of the larval lymphatic system in the zebrafish
Jung, H. M., Castranova, D., Swift, M. R., Pham, V. N., Galanternik, M. V., Isogai, S., Butler, M. G., Mulligan, T. S., & Weinstein, B. M. (2017) · Development · doi:10.1242/dev.145755 · Cited by 98
“…vessel growth and morphogenesis have recently become a subject of intensive investigation in mice and other animal models (Banerji et al., 1999; Fritz-Six et al., 2008; Hermans et al., 2010; Hogan et al., 2009; Hong et al., 2002; Kuchler et al., 2006; Nicenboim et al., 2015; Okuda et al.,…”
BackgroundKoyama, T., Ochoa‐Callejero, L., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Iinuma, N., Arai, T., Yoshizawa, T., Iesato, Y., Yang, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000756 · Cited by 104
“As we and other groups reported previously, in conventional RAMP2 embryos, deformity was detected in both the endothelium and the smooth muscle layer in blood and lymphatic vessels.(25,31) In contrast, in the E-RAMP2 embryos used in this study, the lesion was limited in the ECs, which likely accounts for their longer…”
ResultCXCR7 Targeting and Its Major Disease Relevance
Wang, C., Chen, W., & Shen, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00641 · Cited by 100
Tumor Lymphangiogenesis as a Potential Therapeutic Target
Duong, T., Koopman, P. A., & François, M. (2012) · Journal of Oncology · doi:10.1155/2012/204946 · Cited by 98
“Loss of AM signalling caused abnormal jugular lymphatic vessels due to reduced LEC proliferation [24].”
BackgroundAbnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice
Qu, X., Tompkins, K., Batts, L. E., Puri, M., & Baldwin, H. S. (2010) · Development · doi:10.1242/dev.043380 · Cited by 88
“, 2005), adrenomedullin (Fritz-Six et al., 2008) and Aspp1 (Hirashima et al.”
BackgroundMeningeal lymphatic drainage: novel insights into central nervous system disease
Zhang, Q., Niu, Y., Li, Y., Xia, C., Chen, Z., Chen, Y., & Feng, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02177-z · Cited by 113
Wiig, H., Keskin, D., & Kalluri, R. (2010) · Matrix Biology · doi:10.1016/j.matbio.2010.08.001 · Cited by 95
“…et al., 2006), insulin-like growth factor 1 and 2 (Bjorndahl et al., 2005), platelet derived growth factors (Cao et al., 2004), adrenomedullin (Fritz-Six et al., 2008), growth hormone (Banziger-Tobler et al., 2008) and endothelin (Spinella et al., 2009) as discussed in more detail in recent…”
BackgroundMethodPolycystin Signaling Is Required for Directed Endothelial Cell Migration and Lymphatic Development
Outeda, P., Huso, D. L., Fisher, S. A., Halushka, M. K., Kim, H., Qian, F., Germino, G. G., & Watnick, T. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.064 · Cited by 84
“The relative area of the jugular lymphatic sacs (JLS) was calculated as previously described (Fritz-Six et al., 2008).”
MethodButler, M. G., Isogai, S., & Weinstein, B. M. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20155 · Cited by 89
“Disruption of adrenomedullin signaling results in edema and embryonic lethality, as demonstrated in mice lacking Amd, Calcrl (calcitonin receptor-like), or Ramp2 (receptor activity modifying protein 2) (Fritz-Six et al., 2008).”
BackgroundInfluentialKaafarani, I., Fernandez-Sauze, S., Berenguer‐Daizé, C., Chinot, O. L., Delfino, C., Dussert, C., Métellus, P., Boudouresque, F., Mabrouk, K., Grisoli, F., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-127852 · Cited by 93
“Our data are supported by studies (21, 22) in which CLR and RAMP2 null mice die in utero due to vascular”
BackgroundMolnar, V., Pavelić, E., Vrdoljak, K., Čemerin, M., Klarić, E., Matišić, V., Bjelica, R., Brlek, P., Kovačić, I., Tremolada, C., et al. (2022) · Genes · doi:10.3390/genes13060949 · Cited by 90
NFATc1 regulates lymphatic endothelial development
Kulkarni, R. M., Greenberg, J. M., & Akeson, A. L. (2009) · Mechanisms of Development · doi:10.1016/j.mod.2009.02.003 · Cited by 82
Molecular mechanisms of lymphangiogenesis in development and cancer
Albrecht, I., & Christofori, G. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103226ia · Cited by 79
“Blockade of adrenomedullin (AM) signaling achieved by genetic ablation of either the AM ligand, the AM receptor (CALCRL), the intracellular receptor-activity modifiying protein (RAMP2), or the AM processing enzyme (PAM) leads to decreased LEC proliferation, to the occurrence of smaller lymphatic sacs and to the develo…”
BackgroundJaverzat, S., Franco, M., Herbert, J. M. J., Platonova, N., Peille, A.-L., Pantesco, V., Vos, J. D., Assou, S., Bicknell, R., Bikfalvi, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007856 · Cited by 82
“Between E5 and E7, we found the positive angiogenic and lymphangiogenic regulator RAMP2 [26,27] co-regulated with LYVE1, PECAM1, VWF, SEMA6D and genes, which have not yet been described to play a role in blood vessel growth such as IPMK (inositol polyphosphate multikinase).”
BackgroundInfluentialCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.009 · Cited by 81
Hay, D. L., Walker, C. S., & Poyner, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0244 · Cited by 80
Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo
Dunworth, W. P., Fritz-Six, K. L., & Caron, K. M. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.009 · Cited by 70
“Taken together, these data suggest AM functions as a potent factor in maintaining the blood endothelial barrier; however, whether this function is conserved in LECs and to what extent remains unknown.”
BackgroundMethodSelf-citationShared and separate functions of the RAMP-based adrenomedullin receptors
Kuwasako, K., Kitamura, K., Nagata, S., Hikosaka, T., Takei, Y., & Kato, J. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.022 · Cited by 76
Adrenomedullin and tumour microenvironment
Larráyoz, I. M., Martínez-Herrero, S., García-Sanmartín, J., Ochoa‐Callejero, L., & Martínez, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0339-2 · Cited by 86
“AM signalling directly promotes endothelial cell growth and survival through activation of MAPK/ERK downstream signalling pathways [34].”
BackgroundAdrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema
Jin, D., Harada, K., Ohnishi, S., Yamahara, K., Kangawa, K., & Nagaya, N. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn228 · Cited by 68
“Endogenous AM is necessary for murine lymphatic vascular development during embryogenesis.(19) These findings raise the possibility that AM may play an important role in lymphangiogenesis.”
BackgroundLymphatic deletion of calcitonin receptor–like receptor exacerbates intestinal inflammation
Davis, R. B., Kechele, D. O., Blakeney, E. S., Pawlak, J. B., & Caron, K. M. (2017) · JCI Insight · doi:10.1172/jci.insight.92465 · Cited by 71
“Calcrlfl/fl/Prox1-CreERT2 and Calcrlfl/fl/CAGGCre-ERTM mice were generated by crossing Calcrlfl/fl mice (22), which are on a background of N7-10 on C57BL/6, to either the Prox1-CreERT2 line (24), a gift from Guillermo Oliver (Northwestern University, Chicago, USA) or CAGGCre-ERTM [The Jackson Laboratory B6.”
MethodSelf-citationFetal-derived adrenomedullin mediates the innate immune milieu of the placenta
Li, M., Schwerbrock, N. M. J., Lenhart, P. M., Fritz-Six, K. L., Kadmiel, M., Christine, K. S., Kraus, D. M., Espenschied, S. T., Willcockson, H. H., Mack, C. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67039 · Cited by 65
“We have previously shown that mice with genetic deletion of Calcrl phenotypically recapitulate the embryonic lethality and lymphatic vascular defects observed in Adm–/– mice (36, 40), thereby providing genetic and in vivo evidence to substantiate CLR”
Self-citationValtcheva, N., Primorac, A., Jurisic, G., Hollmén, M., & Detmar, M. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512954 · Cited by 71
Geng, X., Yanagida, K., Akwii, R. G., Choi, D., Chen, L., Ho, Y., Cha, B., Mahamud, M. R., de Ruiz, K. B., Ichise, H., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137652 · Cited by 71
Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling
Pawlak, J. B., Bálint, L., Lim, L. Y., Ma, W., Davis, R. B., Benyó, Z., Soares, M. J., Oliver, G. C., Kahn, M. L., Jakus, Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120446 · Cited by 65
“4 9 1 9jci.org Volume 129 Number 11 November 2019 these biological processes, such as adrenomedullin-CLR signaling, are likely contributing (47, 49).”
BackgroundInfluentialSelf-citationKusano, S., Kukimoto‐Niino, M., Hino, N., Ohsawa, N., Okuda, K., Sakamoto, K., Shirouzu, M., Shindo, T., & Yokoyama, S. (2012) · Protein Science · doi:10.1002/pro.2003 · Cited by 58
Aslam, M., Pfeil, U., Gündüz, D., Rafiq, A., Kummer, W., Piper, H. M., & Noll, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01540.x · Cited by 56
“Thus, RAMP3 did not compensate for the absence of RAMP2 in the RAMP2 mice (Dackor et al., 2006; Fritz-Six et al., 2008).”
BackgroundAdrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Karpinich, N. O., Hoopes, S. L., Kechele, D. O., Lenhart, P., & Caron, K. M. (2011) · Current Hypertension Reviews · doi:10.2174/157340211799304761 · Cited by 60
“5) and recapitulation of Adm-/-, Calcrl-/-, and Ramp2-/- phenotype [22]”
BackgroundInfluentialSelf-citationBerenguer‐Daizé, C., Boudouresque, F., Bastide, C., Tounsi, A., Benyahia, Z., Acunzo, J., Dussault, N., Delfino, C., Baeza, N., Daniel, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0691 · Cited by 58
“Interestingly, the genetic loss of AM, Calcrl, or RAMP2 causes preferential reduction in the proliferation of LECs of the jugular lymphatic vessels (38).”
BackgroundTumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
Fakhrejahani, E., & Toi, M. (2011) · Journal of Oncology · doi:10.1155/2012/261750 · Cited by 59
“VEGF and ANGPTL4 are endothelial cell growth inducers, and ADM is an inducer of lymphatic vessel growth [37, 38].”
Nelson-Maney, N., Bálint, L., Beeson, A. L. S., Serafín, D., Kistner, B. M., Douglas, E. S., Siddiqui, A., Tauro, A. M., & Caron, K. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175616 · Cited by 63
“Calcrl fl/fl mice were generated as previously described (38).”
BackgroundMethodSelf-citationDeficiency of RAMP1 Attenuates Antigen-Induced Airway Hyperresponsiveness in Mice
Li, M., Wetzel-Strong, S. E., Hua, X., Tilley, S. L., Oswald, E., Krummel, M. F., & Caron, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102356 · Cited by 50
“To address this question, we crossed mice with two floxed Calcrl alleles [11] to a smooth muscle-specific Cre line, the SM22-Cre line [19], resulting in mice with a smooth muscle-specific loss of Calcrl, and therefore, a loss of CGRP signaling in this cell type.”
BackgroundMethodSelf-citationHoopes, S. L., Willcockson, H. H., & Caron, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045261 · Cited by 48
“Based on the well-established role of Calcrl in lymphatic vascular development [12], the edema and inflammation in the corneas of Temporal Loss of Calcitonin Receptor-Like Receptor”
InfluentialSelf-citationClinical Potential of Adrenomedullin Signaling in the Cardiovascular System
Bálint, L., Nelson-Maney, N., Tian, Y., Serafin, S. D., & Caron, K. M. (2023) · Circulation Research · doi:10.1161/circresaha.123.321673 · Cited by 51
Self-citationBowles, J., Secker, G. A., Nguyen, C., Kazenwadel, J., Truong, V., Frampton, E., Curtis, C. S., Skoczylas, R., Davidson, T., Miura, N., et al. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.12.008 · Cited by 45
Parnell, S. E., Holloway, H., Baker, L. K., Styner, M. A., & Sulik, K. K. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12464 · Cited by 54
“…has been shown to require adrenomedullin (AM) signaling during this developmental window (Caron and Smithies, 2001), with conditional knockout mice having a reduction in lymphatic endothelial cell proliferation and defects consistent with those in the current investigation (Fritz-Six et al., 2008).”
ResultAdrenomedullin and pregnancy: perspectives from animal models to humans
Lenhart, P., & Caron, K. M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.007 · Cited by 53
Self-citationBooe, J. M., Warner, M. L., Roehrkasse, A. M., Hay, D. L., & Pioszak, A. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.110916 · Cited by 47
“AM signaling is critical during development, as mice lacking AM or its receptor components were embryonic lethal due to cardiovascular and lymphatic defects (Caron and Smithies, 2001; Shindo et al., 2001; Dackor et al., 2006; Fritz-Six et al., 2008).”
BackgroundAn overview of lymphatic vessels and their emerging role in cardiovascular disease
Jones, D., & Wang, M. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.85260 · Cited by 55
“[66] Adrenomedullin and endothelin-1, peptide vasodilator and vasoconstrictor, respectively, contribute to lymphangiogenesis.[67,68] Hormones such as luteinizing hormone, follicle-stimulating hormone, and growth hormone can also stimulate lymphangiogenesis.”
BackgroundHaploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice1
Li, M., Wu, Y., & Caron, K. M. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.069336 · Cited by 45
“Adrenomedullin peptide also acts as an angiogenic factor, and our recent studies in knockout mice have demonstrated that AM signaling is required for the development of the lymphatic vascular system [42].”
BackgroundSelf-citationKadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0400 · Cited by 44
Self-citationZhang, Q., Lee, C., Yang, T., Li, J., Zeng, Q., Liu, X., Liu, Z., Ruan, D., Li, Z., Kan, A. S. Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi4777 · Cited by 48
“ADM global knockout causes intrauterine fetal lethality in mice ( 56 ), which is highly due to placental defects ( 57 ).”
Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
Fischer, J., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2020) · Peptides · doi:10.1016/j.peptides.2020.170347 · Cited by 44
Ochoa‐Callejero, L., Pozo-Rodrigálvarez, A., Martínez‐Murillo, R., & Martínez, A. (2016) · Scientific Reports · doi:10.1038/srep33495 · Cited by 48
Promotion of Lymphatic Integrity by Angiopoietin-1/Tie2 Signaling during Inflammation
Kajiya, K., Kidoya, H., Sawane, M., Matsumoto, Y., Yamanishi, H., Furuse, M., & Takakura, N. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.008 · Cited by 44
A Closer Look at Schlemm’s Canal Cell Physiology: Implications for Biomimetics
Dautriche, C. N., Tian, Y. I., Xie, Y., & Sharfstein, S. T. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6030963 · Cited by 47
“Ramp2 [45],”
Serafín, D., Harris, N. R., Nielsen, N. R., Mackie, D. I., & Caron, K. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.009 · Cited by 44
“A prior role for the AM-CLR-RAMP2 signaling axis in the development of NIHF was established utilizing murine global knockout models of AM, RAMP2 and CLR [45-49].”
BackgroundMethodSelf-citationLymphatic Vasculature: An Emerging Therapeutic Target and Drug Delivery Route
Xu, W., Harris, N. R., & Caron, K. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-051419-114417 · Cited by 43
Self-citationAdrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis
Karpinich, N. O., Kechele, D. O., Espenschied, S. T., Willcockson, H. H., Fedoriw, Y. D., & Caron, K. M. (2012) · The FASEB Journal · doi:10.1096/fj.12-214080 · Cited by 50
“We have also demonstrated recently that AM signaling is required for normal development of the murine lymphatic vascular system, since genetic loss of either Adm or its associated signaling partners, Calcrl or Ramp2, results in embryonic lethality with profound interstitial edema as a consequence of arrested lymphatic…”
BackgroundSelf-citationAdrenomedullin-RAMP2 System in Vascular Endothelial Cells
Koyama, T., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., & Shindo, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29967 · Cited by 42
h CALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia
Mackie, D. I., Mutairi, F. A., Davis, R. B., Kechele, D. O., Nielsen, N. R., Snyder, J. C., Caron, M. G., Kliman, H. J., Berg, J. S., Simms, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180528 · Cited by 45
“…deletion of the genes encoding either AM, CLR, or RAMP2 results in embryonic lethality at mid-gestation characterized by marked HF caused by a developmental arrest of lymphangiogenesis (Caron and Smithies, 2001; Dackor et al., 2006, 2007; Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
InfluentialSelf-citationRamachandran, V., Arumugam, T., Langley, R. R., Hwang, R. F., Vivas‐Mejía, P. E., Sood, A. K., Lopez‐Berestein, G., & Logsdon, C. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007502 · Cited by 47
“Adrenomedullin signaling is necessary for murine lymphatic vascular development [14].”
BackgroundBurger, N. B., Bekker, M. N., de Groot, C. J. M., Christoffels, V. M., & Haak, M. C. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4586 · Cited by 38
“Prox1 induces Adrenomedullin signaling,(44) which might interact with Vegf-A to promote and control LEC proliferation.(44) Two other mutual genes involved in this step of lymphatic vascular development are Cyp51 and Vezf1.”
BackgroundHe, M., He, Q., Cai, X., Chen, Z., Lao, S., Deng, H., Liu, X., Zheng, Y., Liu, X., Liu, J., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-40 · Cited by 40
“It is through its acting on calcitonin receptor-like receptor (CLR) and the associated receptor activity modifying protein 2 (RAMP2), which will lead to increased Erk1/2 activation and LEC proliferation (70).”
BackgroundExcess neuropeptides in lung signal through endothelial cells to impair gas exchange
Xu, J., Xu, L., Sui, P., Chen, J., Moya, E. A., Hume, P. S., Janssen, W. J., Duran, J. M., Thistlethwaite, P. A., Carlin, A. F., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.023 · Cited by 40
Luo, Y., Zhou, H., Liu, L., Shen, T., Chen, W., Xu, B., Han, X., Zhang, F., Scott, R. S., Alexander, J. S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.590 · Cited by 36
“Our data are consistent with the recent findings that activation of ERK pathway promotes lymphoangiogenesis (Fritz-Six et al., 2008; Jin et al., 2008; Ming et al., 2009).”
ResultKong, H., You, N., Chen, H., Teng, Y., Liu, Y., Lv, Y.-P., Mao, F.-Y., Cheng, P., Chen, W., Zhao, Z., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2391-6 · Cited by 37
Vázquez, R., Riveiro, M. E., Berenguer‐Daizé, C., O’Kane, A. A., Gormley, J. A., Touzelet, O., Rezaï, K., Békradda, M., & Ouafik, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.589218 · Cited by 41
Deville, J., Bartoli, C., Berenguer‐Daizé, C., Fernandez-Sauze, S., Kaafarani, I., Delfino, C., Fina, F., Salas, S., Muracciole, X., Mancini, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24568 · Cited by 35
“Recently, Fritz-Six et al.(12) reported that deletion of AM, CLR, or RAMP2 resulted in massive cutaneous edema and midgestation lethality in mice because of defective lymphatic vessel growth.”
BackgroundKim, D.-I., Park, S., Park, S., Ye, M., Chen, J., Kang, S. J., Jhang, J., Hunker, A. C., Zweifel, L. S., Caron, K. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.035 · Cited by 41
Self-citationLiu, X., Cui, K., Wu, H., Li, K. S., Peng, Q., Wang, D., Cowan, D. B., Dixon, J. B., Srinivasan, R. S., Bielenberg, D. R., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318406 · Cited by 40
Robinson, S. D., Aitken, J. F., Bailey, R. J., Poyner, D. R., & Hay, D. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156448 · Cited by 34
“Genetic models of AM, CL, and RAMP2 have provided strong evidence for AM signaling being required for proper blood and lymphatic vascular development (Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
BackgroundWatkins, H. A., Walker, C. S., Ly, K. N., Bailey, R. J., Barwell, J., Poyner, D. R., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12508 · Cited by 34
“AM is involved in the development of the lymphatic and blood vasculature (Hinson et al., 2000; Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
BackgroundAdrenomedullin, a Novel Target for Neurodegenerative Diseases
Ferrero, H., Larráyoz, I. M., Gil-Bea, F. J., Martínez, A., & Ramírez, M. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1031-y · Cited by 34
Identification of key residues involved in adrenomedullin binding to the AM 1 receptor
Watkins, H. A., Au, M., Bobby, R., Archbold, J. K., Abdul-Manan, N., Moore, J., Middleditch, M., Williams, G., Brimble, M. A., Dingley, A. J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12118 · Cited by 33
“…thin blood vessel walls and significant defects observed in the vascular systems of AM, CLR and RAMP2 knock-out mice can be explained by abnormalities in the blood and lymphatic vasculature (Caron and Smithies, 2001; Dackor et al., 2006; 2007; Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
Background
Metadata
- Authors
- Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 1
- Pages
- 40-50
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2147672
- OpenAlex
- W2013443224
- Semantic Scholar
- 240406e3bc090066339dd9f7bf51068c372b4377
- Cited by
- 261
- References
- 59
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 15 · 2023: 11 · 2022: 22 · 2021: 12 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 19 · 2013: 20 · 2012: 17
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Burroughs Wellcome Fund
- American Heart Association
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 046970, R01HD046970)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Medicine › Surgery › Vascular Malformations and Hemangiomas
- Keywords
- adrenomedullin, lymphangiogenesis, calcitonin receptor-like receptor, RAMP2, embryonic lethality, lymphatic endothelial cell proliferation, ERK signaling, Prox1, lymphatic vessels, metastasis, lymphedema treatment
- MeSH terms
- Prospero-Related Homeobox 1 Protein, Animals, Female, Homeostasis, Lymphatic Diseases, Lymphedema, Male, Membrane Proteins, Neoplasm Metastasis, Neoplasms, Pregnancy, Receptors, Calcitonin, Homeodomain Proteins, Neovascularization, Physiologic, MAP Kinase Signaling System, Embryo Loss, Tumor Suppressor Proteins, Lymphatic Vessels, Endothelial Cells, Embryonic Development, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 2, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.